Asaleo Care Price Target Cut 16% to A$1.35/Share by Citi Asaleo Care Downgraded to Sell from Neutral by Citi
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025